Thyrocare Technologies Ltd (THYROCARE) — Board Meeting | 24 September 2026
Thyrocare Technologies approved the grant of 1,92,000 employee stock options at a Rs. 10 exercise price per option under its Employee Stock Option Scheme, effective September 24, 2026, with vesting over three years and a seven-year exercise period.
About Thyrocare Technologies Ltd (THYROCARE)
Healthcare · Healthcare · Listed on BSE
📡 Get AI alerts when THYROCARE files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track THYROCARE — Free💡 Ask AI about this filing
📊 More THYROCARE filings
- 🟡 Voting Results — 28 September 2026Thyrocare Technologies proposed two special resolutions via postal ballot: approval to purchase land...
- 🟡 Board Meeting — 21 September 2026Thyrocare Technologies announced the board approved the sale of its entire 100% stake in radiology s...
- 🔴 Corporate Action — 21 September 2026Thyrocare Technologies announced on September 21, 2026, that its board approved the sale of its enti...
- 🟡 Board Meeting — 21 September 2026Thyrocare Technologies announced on September 21, 2026, that its board approved the sale of its enti...
- 🔴 Insider Trading — 9 September 2026API Holdings released the pledge on 7,94,69,696 Thyrocare shares held by former promoter Docon, full...
🔥 Also filed on 24 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when THYROCARE files new disclosures
Track THYROCARE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track THYROCARE — FreeFree account · 2 AI queries/day